GRP and breast cancer: Several lines of evidence indicate that mammalian bombesin-like peptide receptors, including the GRP and NMB receptors, are frequently overexpressed by a variety of tumor cell lines and tumor specimens from patients with lung, colorectal, gastric, prostate, and breast cancers [8,10,25-27].